CN1175458A - Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases - Google Patents

Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases Download PDF

Info

Publication number
CN1175458A
CN1175458A CN 97116687 CN97116687A CN1175458A CN 1175458 A CN1175458 A CN 1175458A CN 97116687 CN97116687 CN 97116687 CN 97116687 A CN97116687 A CN 97116687A CN 1175458 A CN1175458 A CN 1175458A
Authority
CN
China
Prior art keywords
chinese medicine
radix
cerebrovascular diseases
traditional chinese
treating cardiovascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 97116687
Other languages
Chinese (zh)
Inventor
张玉杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 97116687 priority Critical patent/CN1175458A/en
Publication of CN1175458A publication Critical patent/CN1175458A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

A Chinese patent medicine in the form of capsule for curing cardiovascular and cerebrovascular diseases is prepared from American ginseng, flavescent sophora root, notoginseng and leech, and features distinct curative effect (total effective rate of 98% and cure rate up to 90%), quickly taking its effect and short course of treatment.

Description

The Chinese medicine of treatment cardiovascular and cerebrovascular disease
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease.
Cardiovascular and cerebrovascular disease has become the principal disease of harm contemporary mankind health, particularly threaten senior health and fitness's principal disease, according to statistics, the people that cardiovascular and cerebrovascular disease is died from the annual whole world has more than 1,200 ten thousand, account for about 25% of dead sum, coronary heart disease accounts for the 7-9% of total population sickness rate.Simultaneously, the sickness rate of cardiovascular and cerebrovascular disease is ascendant trend year by year, is again the main cause that causes sudden death, and therefore, the control cardiovascular and cerebrovascular disease has become the problem of world today's property.
At present, the medicine that much suits in clinical diagnosis and treatment is arranged,, all obtained different therapeutic effect, but curative effect is obvious inadequately as HUOLUO WAN, FUFANG DANSHEN PIAN, SHANHAI PILL, XINNAOKANG etc.
The objective of the invention is at the deficiencies in the prior art, a kind of Chinese medicine of evident in efficacy, easy to prepare, treatment cardiovascular and cerebrovascular disease that cost is low is provided.
The object of the present invention is achieved like this: it is the Chinese medicinal capsule that is become by Radix Panacis Quinquefolii, Radix Sophorae Flavescentis, Radix Notoginseng, Hirudo prepared from traditional Chinese medicines, and its prescription (by weight) is:
Radix Panacis Quinquefolii 12-15 part, Radix Sophorae Flavescentis 8-12 part, Radix Notoginseng 6-8 part, Hirudo 15-20 part.
Get the selected medical material of aforementioned proportion, concoct according to a conventional method, pulverize and grind to form fine powder, uniform mixing is dressed up capsule, every capsules content of dispersion 0.25 gram, and usage: oral three times of adult every day, each 4, serious symptom rises to 6 to 8 at every turn, and 15 days is a course of treatment.Anemia of pregnant woman's forbidding is put shady and cool dry place during preservation.
Coronary atherosclerosis, and make luminal stenosis or obturation causes myocardial ischemia, anoxia and the heart disease that causes is called coronary heart disease.Clinical in angina cordis, myocardial infarction, arrhythmia and mental and physical efforts decay etc. are main performance, in treatment, want blood circulation promoting and blood stasis dispelling, coronary circulation-promoting pain-relieving, benefiting qi and nourishing blood, and adjust cerebral cortex, vegetative nerve and metabolism endocrine on the whole, the human body immunity improving function is looked after the various double sick link of blood fat-reducing blood pressure-decreasing.
In the prescription of the present invention: but Radix Panacis Quinquefolii and Radix Sophorae Flavescentis supplementing QI for promoting the production of body fluid, and promoting blood circulation, removing blood stasis and relieving pain is enriched blood and not hot-tempered.But Radix Notoginseng reinforcing the heart gas, the blood that nourishes heart, blood circulation promoting and blood stasis dispelling.Hirudo has dissipation abnormal pigmentary deposit on the skin trace, eliminates the effect of blood vessel accumulation.Reasonable recipe of the present invention, it is superior to draw materials, but blood circulation promoting and blood stasis dispelling, coronary circulation-promoting pain-relieving can be treated diseases such as dizzy uncomfortable in chest, the chest pain of coronary heart disease, angina cordis, myocardial infarction, hypertension, hyperlipidemia, cerebral infarction sequela, brain.Through the clinical proof of taking of thousands of routine patients, total effective rate is 98%, and cure rate is 90%.
Advantage of the present invention is evident in efficacy, and the cure rate height is difficult for recurrence, short treating period, and instant effect has no side effect, and is easy to prepare, and cost is low etc.
Below in conjunction with embodiment to this further instruction of showing effect.
Choose genuine Radix Panacis Quinquefolii 130 grams, Radix Sophorae Flavescentis 100 grams, Radix Notoginseng 80 grams, Hirudo 180 grams, concoct according to a conventional method, grind to form the fine powder uniform mixing, dress up the capsule of every pastille 0.25 gram, it is standby to put shady and cool dry place.

Claims (1)

1, the Chinese medicine of treatment cardiovascular and cerebrovascular disease is characterized in that: it is the Chinese medicinal capsule that is become by Radix Panacis Quinquefolii, Radix Sophorae Flavescentis, Radix Notoginseng, Hirudo prepared from traditional Chinese medicines, and its prescription (by weight) is:
Radix Panacis Quinquefolii 12-15 part, Radix Sophorae Flavescentis 8-12 part, Radix Notoginseng 6-8 part, Hirudo 15-20 part.
CN 97116687 1997-09-05 1997-09-05 Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases Pending CN1175458A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 97116687 CN1175458A (en) 1997-09-05 1997-09-05 Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 97116687 CN1175458A (en) 1997-09-05 1997-09-05 Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases

Publications (1)

Publication Number Publication Date
CN1175458A true CN1175458A (en) 1998-03-11

Family

ID=5174035

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 97116687 Pending CN1175458A (en) 1997-09-05 1997-09-05 Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases

Country Status (1)

Country Link
CN (1) CN1175458A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067961A3 (en) * 2001-02-26 2003-05-15 Global Cancer Strategies Ltd Therapeutic uses of herbal compositions
US7381429B2 (en) 2000-06-29 2008-06-03 Dr. Willmar Schwabe Gmbh & Co. Extracts from sophora species, method for producing the same and their use
CN102600255A (en) * 2012-03-29 2012-07-25 周柳池 Coronary disease treatment capsule

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381429B2 (en) 2000-06-29 2008-06-03 Dr. Willmar Schwabe Gmbh & Co. Extracts from sophora species, method for producing the same and their use
WO2002067961A3 (en) * 2001-02-26 2003-05-15 Global Cancer Strategies Ltd Therapeutic uses of herbal compositions
CN102600255A (en) * 2012-03-29 2012-07-25 周柳池 Coronary disease treatment capsule

Similar Documents

Publication Publication Date Title
CN100382839C (en) Chinese-medicinal composition for treating coronary heart disease
CN102406911A (en) Chinese medicine preparation for treating coronary heart disease
CN103393749A (en) Traditional Chinese medicine for preventing and treating ischemic cardiovascular and cerebrovascular diseases
CN1175458A (en) Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases
CN101564505B (en) Chinese medicament for treating pulmonary heart disease
Min et al. Case report of Korean medical treatment of chest pain after percutaneous coronary intervention
CN101024048A (en) Medicine for treating heart disease
CN101537114B (en) Chinese medicine for treating arrhythmia
CN108014267A (en) A kind of liter is immunized, reducing blood lipid, the Chinese medicine composition and preparation method thereof for protecting heart and brain
CN111388623B (en) Traditional Chinese medicine for treating coronary heart disease
CN101850055B (en) Chinese medicament for treating coronary heart diseases
CN101554412B (en) Traditional Chinese medicine for treating atrial fibrillation
CN102266528B (en) Medicament for treating hypertension
CN101843644B (en) Chinese medicament for treating tachycardia
CN1116060C (en) Five-medicine tranquilization preparation
CN101843758B (en) Chinese medicament for treating coronary disease
CN101843712A (en) Chinese medicament for treating angina
CN1081930C (en) Medicine powder for treating bone Bi-syndrome and its preparation
CN1242198A (en) Traditional Chinese medicine capsule for treating coronary heart disease
CN103239583B (en) Airuike heart-soothing granule
CN101564476B (en) Chinese medicament for treating coronary heart disease
CN101850034B (en) Chinese medicament for treating angina
CN1168483C (en) Heart disease treating medicine
CN1124149C (en) Chinese medicine capsule mainly for treating cerebral infraction
CN1102057C (en) Plant day cream for treating cystis and nodular acne

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication